AsymMirai from Duke University is an AI diagnostic tool that can identify potential breast cancer five years before it develops, according to findings published in Radiology. AsymMirai is a better option than previous AI tools because it looks at small differences between the tissues in the right and left breasts. Medical staff find it simpler to assess cancer risk via routine mammograms using AsymMirai as an AI tool which provides accurate results better than earlier AI methods.
The medical statistics in America suggest that breast cancer will detect invasive cases in one of eight women throughout their existence. Research predicts a total number of 300,000 new breast cancer cases for 2023 with an expected death toll of nearly 43,700 female patients. The incidence of breast cancer among men is low but has estimated 500 deaths in combination with 3,800 diagnosed cases within this year. Breast cancer remains a major health challenge in society despite early detection being possible through mammograms which improve survival rates.
The development of AsymMirai comes at a crucial time, given the ongoing seriousness of breast cancer. Early diagnosis is the key to improving survival rates, though traditional risk evaluation methods sometimes fail to provide reliable results. AsymMirai offers healthcare providers accurate ways to assess potential risks, which can lead to better medical outcomes in the future. It can save lives and reduce the impact of breast cancer on families worldwide.
Source: Bongo Wiki
